Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5036505 in moderate-to-severe asthma
NCT00967590Phase 2Withdrawn
- Sponsor
- Roche
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of RO5036505 in asthma, sponsored by Roche. Planned start Sep 2009; status: withdrawn.
02
Drugs
RO5036505
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00967590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967590.